King Pharmaceuticals News
Most Popular King Pharmaceuticals Story
King Pharma loses patents for top-selling Skelaxin
In a blow to King Pharmaceuticals, a judge at the U.S. District Court in New York invalidated two of three patents for the drugmakers' top selling drug, muscle relaxant Skelaxin. The patent challenge... Read more...
Latest Headlines
- December 9, 2009
- November 24, 2009
- August 13, 2009
- April 27, 2009
- February 3, 2009
- January 21, 2009
- November 24, 2008
- October 7, 2008
- September 11, 2008
- September 2, 2008
- August 22, 2008
- October 22, 2007
- September 13, 2007
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
